Graduate Students

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

Hands-on workshop: Learn how to make your own science outreach and protocol videos

admin — Tue, 19 Aug 2025 15:35:20 +0000

Atelier "Atelier pratique : Apprenez à créer vos propres vidéos de vulgarisation scientifique et de protocole"

Cet atelier sera présenté en anglais.

iPSC Seminars: Early Drug Discovery Unit (EDDU)

admin — Thu, 31 Jul 2025 15:32:34 +0000

THE NEURO'S EDDU iPSC SEMINAR SERIES

Modeling α-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

admin — Tue, 05 Aug 2025 17:49:37 +0000

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research.

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Neuro Epilepsy Lecture Series: The Neurophysiological Basis of Internal Attention

admin — Fri, 05 Sep 2025 13:36:41 +0000

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research.

ECHO-Autism: Differential Diagnosis

admin — Thu, 07 Aug 2025 15:17:04 +0000

ECHO-Autism: Differential Diagnosis September 11, 2025 1:00 to 2:30 p.m. (ET) Virtual training (online)

Open Science Office Hours - – Imaging and Workflows

admin — Tue, 19 Aug 2025 15:10:51 +0000

Atelier "Imagerie et flux de travail"

Cet atelier sera présenté en anglais.

Lundi, le 22 September 2025
16 – 17 h HNE

En ligne, sur Zoom.

51�Թ��Cares: Let’s talk about aging parents

diane.weidner@mcgill.ca — Fri, 05 Sep 2025 19:27:42 +0000

Join us on October 15, 2025 at noon for our next episode of 51�Թ��Cares, a webcast series designed to support informal caregivers.

Sylvain Baillet inducted into the Royal Society of Canada

admin — Thu, 04 Sep 2025 14:34:58 +0000

Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life

Sylvain Baillet, PhD, a global leader in brain imaging and systems neuroscience, has been inducted into the Royal Society of Canada, one of the nation’s highest academic honours.

51�Թ��Cares: Caring for someone with dementia: What you need to know about hallucinations, delusions and paranoia

diane.weidner@mcgill.ca — Fri, 29 Aug 2025 19:21:26 +0000

Join us on September 17, 2025 at noon as we launch our sixth season of 51�Թ��Cares, a webcast series designed to support informal caregive

Alan Evans receives Order of Canada

admin — Mon, 30 Jun 2025 21:35:08 +0000

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 51�Թ�� and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.